Logo image of IPDN

PROFESSIONAL DIVERSITY NETWO (IPDN) Stock Fundamental Analysis

NASDAQ:IPDN - Nasdaq - US74312Y4008 - Common Stock - Currency: USD

1.64  -0.01 (-0.61%)

After market: 1.75 +0.11 (+6.71%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to IPDN. IPDN was compared to 82 industry peers in the Professional Services industry. While IPDN seems to be doing ok healthwise, there are quite some concerns on its profitability. IPDN does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year IPDN has reported negative net income.
IPDN had a negative operating cash flow in the past year.
IPDN had negative earnings in each of the past 5 years.
IPDN had a negative operating cash flow in each of the past 5 years.
IPDN Yearly Net Income VS EBIT VS OCF VS FCFIPDN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -10M -20M -30M

1.2 Ratios

IPDN has a worse Return On Assets (-31.56%) than 90.24% of its industry peers.
IPDN's Return On Equity of -49.69% is on the low side compared to the rest of the industry. IPDN is outperformed by 82.93% of its industry peers.
Industry RankSector Rank
ROA -31.56%
ROE -49.69%
ROIC N/A
ROA(3y)-45.88%
ROA(5y)-43.71%
ROE(3y)-96.86%
ROE(5y)-103.87%
ROIC(3y)N/A
ROIC(5y)N/A
IPDN Yearly ROA, ROE, ROICIPDN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 1K 1.5K 2K

1.3 Margins

The Gross Margin of IPDN (58.32%) is better than 70.73% of its industry peers.
IPDN's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for IPDN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 58.32%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.78%
GM growth 5Y-5.91%
IPDN Yearly Profit, Operating, Gross MarginsIPDN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

4

2. Health

2.1 Basic Checks

IPDN does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for IPDN has been increased compared to 1 year ago.
Compared to 5 years ago, IPDN has more shares outstanding
IPDN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
IPDN Yearly Shares OutstandingIPDN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M
IPDN Yearly Total Debt VS Total AssetsIPDN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

Based on the Altman-Z score of -18.30, we must say that IPDN is in the distress zone and has some risk of bankruptcy.
IPDN has a Altman-Z score of -18.30. This is amonst the worse of the industry: IPDN underperforms 95.12% of its industry peers.
IPDN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -18.3
ROIC/WACCN/A
WACC9.11%
IPDN Yearly LT Debt VS Equity VS FCFIPDN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M

2.3 Liquidity

IPDN has a Current Ratio of 0.54. This is a bad value and indicates that IPDN is not financially healthy enough and could expect problems in meeting its short term obligations.
IPDN's Current ratio of 0.54 is on the low side compared to the rest of the industry. IPDN is outperformed by 91.46% of its industry peers.
IPDN has a Quick Ratio of 0.54. This is a bad value and indicates that IPDN is not financially healthy enough and could expect problems in meeting its short term obligations.
IPDN's Quick ratio of 0.54 is on the low side compared to the rest of the industry. IPDN is outperformed by 90.24% of its industry peers.
Industry RankSector Rank
Current Ratio 0.54
Quick Ratio 0.54
IPDN Yearly Current Assets VS Current LiabilitesIPDN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

1

3. Growth

3.1 Past

IPDN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 53.53%, which is quite impressive.
IPDN shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -12.87%.
Measured over the past years, IPDN shows a small growth in Revenue. The Revenue has been growing by 6.00% on average per year.
EPS 1Y (TTM)53.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%44.72%
Revenue 1Y (TTM)-12.87%
Revenue growth 3Y3.33%
Revenue growth 5Y6%
Sales Q2Q%-12.87%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
IPDN Yearly Revenue VS EstimatesIPDN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
IPDN Yearly EPS VS EstimatesIPDN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 -50 -100 -150 -200

0

4. Valuation

4.1 Price/Earnings Ratio

IPDN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
IPDN Price Earnings VS Forward Price EarningsIPDN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
IPDN Per share dataIPDN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

IPDN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

PROFESSIONAL DIVERSITY NETWO

NASDAQ:IPDN (6/12/2025, 2:12:32 PM)

After market: 1.75 +0.11 (+6.71%)

1.64

-0.01 (-0.61%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)05-14 2025-05-14
Earnings (Next)08-11 2025-08-11
Inst Owners7.07%
Inst Owner Change-90.28%
Ins Owners7.72%
Ins Owner Change0%
Market Cap3.41M
Analysts82.86
Price TargetN/A
Short Float %3.83%
Short Ratio0.22
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.52
P/FCF N/A
P/OCF N/A
P/B 0.69
P/tB 1.11
EV/EBITDA N/A
EPS(TTM)-1.71
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-1.16
FCFYN/A
OCF(TTM)-1.08
OCFYN/A
SpS3.13
BVpS2.36
TBVpS1.48
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -31.56%
ROE -49.69%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 58.32%
FCFM N/A
ROA(3y)-45.88%
ROA(5y)-43.71%
ROE(3y)-96.86%
ROE(5y)-103.87%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.78%
GM growth 5Y-5.91%
F-Score4
Asset Turnover0.84
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 93.76%
Cap/Sales 2.77%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.54
Quick Ratio 0.54
Altman-Z -18.3
F-Score4
WACC9.11%
ROIC/WACCN/A
Cap/Depr(3y)56.86%
Cap/Depr(5y)38.88%
Cap/Sales(3y)2.46%
Cap/Sales(5y)1.75%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)53.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%44.72%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-12.87%
Revenue growth 3Y3.33%
Revenue growth 5Y6%
Sales Q2Q%-12.87%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y45.23%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y15.58%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y5.78%
OCF growth 3YN/A
OCF growth 5YN/A